VirTrial has announced a training and certificate program to help research sites prepare for hybrid clinical trials which include a combination of virtual and in-person visits, the company said.
The program is free to all Society for Clinical Research Sites (SCRS) member sites domestically and abroad.
VirTrial is a telehealth platform provider that enables virtual visits to reduce the burden on patients and improve efficiencies for sites. The platform is available for use on any device, including patients´ personal devices (Apple, Android, tablet and/or computer) and will work for any research site. By combining video, text, and email, clinical trial sites can easily address specific patient and study needs in a secure environment.
The new training program includes four brief modules sites will complete in order to become certified as Virtual Trial Capable. Once completed, sites will receive a Virtual Trial Capable Certificate and badge which can be used to display to sponsors and CROs. As part of the program, VirTrial will regularly provide sponsors and CROs with a list of Virtual Trial Capable sites.
VirTrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trials industry. The platform offers a patient management program that combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric trials by replacing some study visits with virtual visits. To learn more about VirTrial, visit https://www.VirTrial.com.
Founded in 2012, SCRS is a global organization that unifies the voice of the clinical research site community to create greater site sustainability. Representing over 9,500 sites in 47 countries, SCRS membership provides sites with a community dedicated to advocacy, education, mentorship and connectivity. Visit MySCRS.org.